Intrafamilial and interfamilial heterogeneity of PINK1-associated Parkinson's disease in Sudan.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
06 2023
Historique:
received: 26 01 2023
revised: 10 04 2023
accepted: 11 04 2023
medline: 6 6 2023
pubmed: 8 5 2023
entrez: 7 5 2023
Statut: ppublish

Résumé

PINK1 is the second most predominant gene associated with autosomal recessive Parkinson's disease. Homozygous mutations in this gene are associated with an early onset of symptoms. Bradykinesia, tremors, and rigidity are common features, while dystonia, motor fluctuation, and non-motor symptoms occur in a lower percentage of cases and usually respond well to levodopa. We investigated 14 individuals with parkinsonism and eleven symptom-free siblings from three consanguineous Sudanese families, two of them multigenerational, using a custom gene panel screening 34 genes, 27 risk variants, and 8 candidate genes associated with parkinsonism. We found a known pathogenic nonsense PINK1 variant (NM_032409.3:c.1366C>T; p.(Gln456*)), a novel pathogenic single base duplication (NM_032409.3:c.1597dup; p.(Gln533Profs*29)), and another novel pathogenic insertion (NM_032409.3:c.1448_1449ins[1429_1443; TTGAG]; p.(Arg483Serfs*7)). All variants were homozygous and co-segregated in all affected family members. We also identified intrafamilial and interfamilial phenotypic heterogeneity associated with PINK1 mutations in these Sudanese cases, possibly reflecting the nature of the Sudanese population that has a large effective population size, which suggests a higher possibility of novel findings in monogenic and polygenic diseases in Sudan.

Identifiants

pubmed: 37150071
pii: S1353-8020(23)00124-4
doi: 10.1016/j.parkreldis.2023.105401
pii:
doi:

Substances chimiques

Protein Kinases EC 2.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105401

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Yousuf Bakhit (Y)

Department of Neurology, University Hospital Bonn, Germany; Department of Basic Medical Sciences, Faculty of Dentistry, University of Khartoum, Sudan; Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan. Electronic address: npgy1@yahoo.com.

Mohamed O Ibrahim (MO)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan; Department of Biochemistry, Faculty of Medicine, Sudan University of Science and Technology, Khartoum, Sudan.

Christelle Tesson (C)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France.

Ali A Elhassan (AA)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Mohamed Anwer Ahmed (MA)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Mohamed A Alebeed (MA)

Department of Biochemistry, Faculty of Medicine, Sudan University of Science and Technology, Khartoum, Sudan.

Salma M Elrasheed (SM)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Mawia A Omar (MA)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Rayan Abubaker (R)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Khalid Eltom (K)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan; Department of Medical Cell Biology, Uppsala Biomedical Center, Uppsala University, Uppsala, Sweden.

Mutaz T Shaheen (MT)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Yousuf A Ibrahim (YA)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Murad E Almak (ME)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Hiba A Ali (HA)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Ahmed A Abugrain (AA)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Mohamed A Almahal (MA)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Abubaker A MohamedSharif (AA)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan; Department of Anatomy, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.

Mohamed Y Tahir (MY)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Sawazen M Malik (SM)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Hazim Eldirdiri Abdelrahman (H)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan; Institute of Psychiatry and Neuroscience of Paris, 102 rue de la Sante, 75014, Paris, France.

Reem J Khidir (RJ)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Malaz T Mohamed (MT)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan.

Abdelmohaymin Abdalla (A)

Sudan Neuroscience Projects (SNPs), University of Khartoum, Khartoum, Sudan; Department of Pulmonary and Critical Care, Mayo Clinic, Phoenix, AZ, USA.

Liena E O Elsayed (LEO)

Department of Basic Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.

Suzanne Lesage (S)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France.

Jean-Christophe Corvol (JC)

Sorbonne Université, Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France.

Osheik Seidi (O)

Department of Neurology, Soba Teaching Hospital, And Department of Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.

Ullrich Wüllner (U)

Department of Neurology, University Hospital Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. Electronic address: ullrich.wuellner@ukbonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH